Posted: June 22, 2015
Salt Lake City, June 22, 2015 – Nelson Laboratories will be hosting a series of Career Exploration Open Houses June 25, 2015, July 30, 2015, and August 27, 2015 and invites emerging and established professionals alike to learn more about current and future career opportunities this science-driven organization has to offer.
Posted: March 19, 2015
Scientists at Nelson Laboratories Discover Extractable Positive Control for In Vitro Skin Irritation Testing of Medical Devices
The tide of in vitro medical device testing is changing with the discovery of an extractable positive control at Salt Lake City, UT based microbiology lab, Nelson Laboratories. A major element in the development and validation of in vitro alternatives to in vivo animal testing, this discovery may mean regulatory acceptance of in vitro testing is much closer than previously expected.
Posted: February 25, 2015
Nelson Laboratories opens new analytical chemistry lab, expanding its in-house service offering to include additional analytical instrumentation capabilities like chemical characterization testing of medical devices, qualitative and quantitative analysis of metals, qualitative and quantitative analysis of volatile, semi-volatile, and non-volatile organic compounds, and determination of leachable and extractable compounds.
Posted: January 27, 2015
Since 1985, Nelson Labs has partnered with the best companies in the world to improve the quality of life by bringing life-enhancing products to market. We share a proud history with you as we have tested many of your new and innovative products. To show our appreciation for your partnership, we invite you to join us in celebrating our 30th anniversary at our Anaheim open house February 11, 2015!
Posted: October 24, 2014
Certified microbiologist and recognized biocompatibility expert Thor Rollins of Salt Lake City, Utah based Nelson Laboratories, Inc. to present half-day lecture series at MD&M Minneapolis. With a focus on the evolving nature of biocompatibility testing and compliance for medical devices, Rollins’ lecture series reviews current biocompatibility testing standards in the context of regulatory behavior.